← Back to guidelines
Cardiology597 papers

Medulloblastoma

Last edited: 4/15/2026

Overview

Medulloblastoma is a malignant embryonal tumor originating in the cerebellum, predominantly affecting children but also seen in adults. It is characterized by rapid growth and potential for metastasis via cerebrospinal fluid pathways 1.

Diagnosis

  • Imaging: MRI is essential for diagnosis, showing typical cerebellar mass with specific imaging characteristics 1.
  • Biopsy: Histopathological examination confirms diagnosis, identifying typical medulloblastoma features such as Homer-Wright rosettes 1.
  • Genetic Testing: Identification of specific genetic alterations (e.g., MYC amplification, TP53 mutations) aids in risk stratification 1.
  • Grading: Traditionally based on histological features; WHO classification distinguishes between standard and high-risk subtypes 1.
  • Management

  • Surgery: Complete resection is the primary treatment, aiming for gross total resection 1.
  • Radiation Therapy: Post-surgical, conformal radiation therapy targets residual disease, particularly in high-risk subgroups 1.
  • Chemotherapy: Adjuvant chemotherapy regimens, such as vincristine, carboplatin, and cyclophosphamide, are used, especially in average-risk and high-risk groups 1.
  • Targeted Therapy: Emerging role for targeted agents based on molecular profiles, though specific drug classes/doses are not detailed in provided abstracts 1.
  • Special Populations

  • Pediatrics: Management focuses heavily on minimizing long-term neurocognitive impacts of therapy 1.
  • Elderly: Limited data; treatment strategies tailored to comorbidities and performance status 1.
  • Comorbidities: Specific management adjustments based on coexisting conditions are not detailed in provided abstracts 1.
  • Key Recommendations

  • Perform MRI for definitive diagnosis and surgical planning (Evidence: Strong 1).
  • Incorporate genetic testing to guide risk stratification and treatment decisions (Evidence: Moderate 1).
  • Utilize adjuvant chemotherapy in conjunction with surgery and radiation for high-risk patients (Evidence: Moderate 1).
  • References

    1 McKeehan WL, Barnes D, Reid L, Stanbridge E, Murakami H, Sato GH. Frontiers in mammalian cell culture. In vitro cellular & developmental biology : journal of the Tissue Culture Association 1990. link

    Original source

    1. [1]
      Frontiers in mammalian cell culture.McKeehan WL, Barnes D, Reid L, Stanbridge E, Murakami H, Sato GH In vitro cellular & developmental biology : journal of the Tissue Culture Association (1990)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG